Shafaat Ahmed Rabbani

8PUBLICATIONS
13CO-AUTHORS
Molecular targetsUrban hydrologyCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jul 10, 2026
A potent small-chemical MBD2 inhibitor, KCC-07, induces selective cytotoxicity in hepatocellular and prostate cancer cells.

|Oct 29, 2025
The Urokinase-Type Plasminogen Activator Receptor (uPAR) as a Mediator of Physiological and Pathological Processes: Potential Therapeutic Strategies.

Ali Iftikhar, Niaz Mahmood, Shafaat A Rabbani

|Jan 08, 2023
Co-Targeting Luminal B Breast Cancer with S-Adenosylmethionine and Immune Checkpoint Inhibitor Reduces Primary Tumor Growth and Progression, and Metastasis to Lungs and Bone.

Ali Mehdi, Mikhael Attias, Ani Arakelian

|Nov 03, 2022
Epigenomic effects of vitamin D in colorectal cancer.

Reza Khayami, David Goltzman, Shafaat A Rabbani

|Apr 30, 2021
Fibrinolytic System and Cancer: Diagnostic and Therapeutic Applications.

Niaz Mahmood, Shafaat A Rabbani

|Feb 04, 2021
Role of Methylation in Pro- and Anti-Cancer Immunity.

Ali Mehdi, Shafaat A Rabbani

Pageof 2

Frequent Collaborators

2 joint publications

Niaz Mahmood

2 joint publications

Ali Iftikhar

1 joint publications

Reza Khayami

1 joint publications

David Goltzman